Two is better than one

If you are here, you have probably heard about the enormous potential of digital PCR in cancer research.

Samples are precious. Target mutations are often present in low abundance or in the complex backgrounds of other components.

An approach like digital PCR is useful for identifying and measuring rare sequences or mutations, monitoring cancer progression and treatment effects, and detecting relapses early with high sensitivity. Apart from detecting cancer point mutations, digital PCR can also detect fusion genes and CNVs.

Why not use a simple, rapid plate-based digital PCR system for cancer research?

Our specialists are eager to help. Fill out the form below to request an on-site demo of QIAcuity. Explore the technology up close and in detail. Get answers to your questions about how QIAcuity can improve specific protocols and existing workflows.

Tip: Consider the power of two for your cancer research workflow.

With EZ2 Connect, you can combine high-volume processing of various sample types and analytes with ultra-low mutation detection on QIAcuity. So why not have our specialists over for a demo of both instruments in one visit?